Atlas Trials

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Clinical trial NCT04929028 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04929028
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
AIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell CarcinomaAnal Squamous Cell CarcinomaHIV InfectionRectal Squamous Cell CarcinomaStage II Rectal Cancer AJCC v8Stage IIB Anal Cancer AJCC v8Stage III Anal Cancer AJCC v8Stage III Rectal Cancer AJCC v8
Start date
2022-08-09
Primary completion
2031-09-15
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.